The promising interplay between sonodynamic therapy and nanomedicine

Area of Science:

• Biomedical Engineering
• Oncology
• Materials Science

Background:

• Sonodynamic therapy (SDT) is an emerging non-invasive cancer treatment utilizing ultrasound-activated sonosensitizers.
• The precise mechanisms underlying SDT's therapeutic effects remain incompletely understood, hindering clinical translation.
• Understanding sonosensitizer properties and cellular localization is crucial for predicting bioeffects.

Purpose of the Study:

• To review the primary mechanisms of SDT.
• To emphasize the role of sonosensitizer physicochemical properties and cellular localization.
• To highlight nanomedicine's contribution to advancing SDT.

Main Methods:

• Literature review focusing on SDT mechanisms and sonosensitizers.
• Analysis of the impact of sonosensitizer properties on therapeutic outcomes.
• Exploration of nanomedicine's role in developing ultrasound-responsive agents.

Main Results:

• SDT mechanisms are influenced by sonosensitizer characteristics and cellular uptake.
• Nanomaterials can be engineered as therapeutic agents, enhancing sonodynamic effects like sonoluminescence.
• The evolution of nanosystems marks a significant advancement in SDT development.

Conclusions:

• Physicochemical properties and cellular localization of sonosensitizers are key determinants of SDT efficacy.
• Nanomedicine offers innovative strategies to optimize SDT by designing responsive agents.
• Further research in nanomedicine-driven SDT holds promise for improved cancer therapy implementation.